Evidence map›Paper›PMID 34508571›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2022

Screening Health-Promoting Compounds for Their Capacity to Induce the Activity of FOXO3.

Lucia Jimenez, Andreia Silva, Giampaolo Calissi, Inês Grenho, Rita Monteiro, Victor Mayoral-Varo, Carmen Blanco-Aparicio, Joaquin Pastor, Victor Bustos, Franz Bracher and 3 more

Abstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Use of Microfluidics for Study of FOXO3 Translocation Dynamics.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  3. Reporter Gene Assays to Measure FOXO-Specific Transcriptional Activity.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. FOXO3, a Resilience Gene: Impact on Lifespan, Healthspan, and Deathspan.The journals of gerontology. Series A, Biological sciences and medical sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lucia JimenezInstituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM), Madrid, Spain.ORCID 0000-0001-9576-1766
Andreia SilvaCentre for Biomedical Research (CBMR), University of Algarve, Campus of Gambelas, Faro, Portugal.
Giampaolo CalissiInstituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM), Madrid, Spain.ORCID 0000-0001-7997-0728
Inês GrenhoCentre for Biomedical Research (CBMR), University of Algarve, Campus of Gambelas, Faro, Portugal.
Rita MonteiroCentre for Biomedical Research (CBMR), University of Algarve, Campus of Gambelas, Faro, Portugal.
Victor Mayoral-VaroInstituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM), Madrid, Spain.
Carmen Blanco-AparicioSpanish National Cancer Research Centre (CNIO), Madrid, Spain.
Joaquin PastorSpanish National Cancer Research Centre (CNIO), Madrid, Spain.
Victor BustosRefoxy Pharmaceuticals GmbH, Berlin, Germany.ORCID 0000-0002-2251-8295
Franz BracherDepartment of Pharmacy, Center for Drug Research, Ludwig-Maximilians University, Munich, Germany.
Diego MegíasSpanish National Cancer Research Centre (CNIO), Madrid, Spain.
Bibiana I FerreiraCentre for Biomedical Research (CBMR), University of Algarve, Campus of Gambelas, Faro, Portugal.
Wolfgang LinkInstituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM), Madrid, Spain.ORCID 0000-0002-3340-5165

Funding

Centre for Biomedical ResearchDeutsche Forschungsgemeinschaft BR1034/6-1Fundação para a Ciência e a Tecnologia UID/BIM/04773/2013Spanish Ministry of Science, Innovation and Universities RTI2018-094629-B-I00
6 · The paper itself

Abstract

Several chemical compounds including natural products have been suggested as being effective against age-related diseases or as beneficial for a healthy life. On the other hand, forkhead box O (FOXO) proteins are emerging as key cellular components associated with extreme human longevity. FOXO proteins are mainly regulated by posttranslational modifications and as these modifications are reversible, activation and inactivation of FOXO are attainable through pharmacological treatment. Here, we questioned whether a panel of compounds with known health-beneficial properties has the capacity to induce the activity of FOXO factors. We show that resveratrol, a phytoalexin present in grapes and other food products, the amide alkaloid piperlongumine found in the fruit of the long pepper, and the plant-derived β-carboline compound harmine induced nuclear translocation of FOXO3. We also show that piperlongumine and harmine but not resveratrol activate FOXO-dependent transcription. We determined the half maximal effective concentration (EC50) values for resveratrol, piperlongumine, and harmine for FOXO translocation, and analyzed their inhibitory impact on chromosomal maintenance 1 (CRM1)-mediated nuclear export and the production of reactive oxygen species (ROS). We also used chemical biology approach and Western blot analysis to explore the underlying molecular mechanisms. We show that harmine, piperlongumine, and resveratrol activate FOXO3 independently of phosphoinositide 3-kinase (PI3K)/AKT signaling and the CRM1-mediated nuclear export. The effect of harmine on FOXO3 activity is at least partially mediated through the inhibition of dual-specificity tyrosine (Y) phosphorylationregulated kinase 1A (DYRK1A) and can be reverted by the inhibition of sirtuins (SIRTs).

Indexed as

Forkhead Box Protein O3Proto-Oncogene Proteins c-aktDioxolanesExportin 1 ProteinHarmineHumansKaryopherinsPhosphatidylinositol 3-KinasesPiperidonesReceptors, Cytoplasmic and NuclearResveratrolDioxolanesExportin 1 ProteinForkhead Box Protein O3FOXO3 protein, humanHarmineKaryopherinsPhosphatidylinositol 3-KinasesPiperidonespiperlongumineProto-Oncogene Proteins c-aktReceptors, Cytoplasmic and NuclearResveratrolAgingFOXO3High-content screeningLongevityNatural products

Identifiers

PMID34508571
PMCPMC9373959

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.